0001375151-19-000019.txt : 20190305
0001375151-19-000019.hdr.sgml : 20190305
20190305160941
ACCESSION NUMBER: 0001375151-19-000019
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190301
FILED AS OF DATE: 20190305
DATE AS OF CHANGE: 20190305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GARNER CAM L
CENTRAL INDEX KEY: 0001024007
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34962
FILM NUMBER: 19658395
MAIL ADDRESS:
STREET 1: PO BOX 675866
CITY: RANCHO SANTE FE
STATE: CA
ZIP: 92067
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ZOGENIX, INC.
CENTRAL INDEX KEY: 0001375151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205300780
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5858 HORTON STREET, #455
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 550-8300
MAIL ADDRESS:
STREET 1: 5858 HORTON STREET, #455
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: ZOGENIX INC
DATE OF NAME CHANGE: 20060911
4
1
wf-form4_155182016716604.xml
FORM 4
X0306
4
2019-03-01
0
0001375151
ZOGENIX, INC.
ZGNX
0001024007
GARNER CAM L
C/O ZOGENIX, INC.
5959 HORTON STREET, SUITE 500
EMERYVILLE
CA
94608
1
0
0
0
Common Stock
2019-03-01
4
M
0
6250
15.52
A
6250
D
Common Stock
2019-03-01
4
M
0
9000
12.80
A
15250
D
Common Stock
2019-03-01
4
S
0
15250
50
D
0
D
Common Stock
40843
I
By Garner Investments, LLC
Stock Option (Right to Buy)
15.52
2019-03-01
4
M
0
6250
0
D
2024-05-20
Common Stock
6250.0
0
D
Stock Option (Right to Buy)
12.8
2019-03-01
4
M
0
9000
0
D
2025-06-17
Common Stock
9000.0
0
D
The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
The option was granted on May 21, 2014 and vests in a series of twelve (12) successive, equal monthly installments measured from the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date.
The option was granted on June 18, 2015 and vests in a series of twelve (12) successive, equal monthly installments measured from the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date.
/s/ Thomas Doyle, Attorney-in-fact for Cam L. Garner
2019-03-04